Tryptamine-induced tryptophanyl-tRNAtrp deficiency in neurodifferentiation and neurodegeneration interplay: Progenitor activation with neurite growth terminated in alzheimer's disease neuronal vesicularization and fragmentation

Journal of Alzheimer's Disease

Volumn 26, Issue 2, 2011, Pages 263-298

  Paley, Elena L ^a,b  

^a NOVA SOUTHEASTERN UNIVERSITY   (United States)

^b Expert BioMed Inc   (United States)

Author keywords

Alzheimer's disease; human brain; neurodifferentiation; neuronal vesicularization; progenitor; tryptamine; tryptophan; tryptophanyl tRNA synthetase

Indexed keywords

AMYLOID; SEROTONIN; TRANSFER RNA; TRYPTAMINE; TRYPTOPHAN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ACTIVATION; CELL DIVISION; CELL MEMBRANE; COLONY FORMING UNIT GM; CONTROLLED STUDY; CORRELATION ANALYSIS; EPITHELIOID CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOTHESIS; IMMUNOREACTIVITY; ISOTOPE LABELING; MALE; MOUSE; NERVE CELL DIFFERENTIATION; NERVE DEGENERATION; NERVE FIBER; NERVE FIBER GROWTH; NEUROBLAST; NEUROBLASTOMA; NEUROFILAMENT; NONHUMAN; PRIORITY JOURNAL; SATELLITE CELL; SEROTONIN UPTAKE; STEM CELL; SYNAPSE VESICLE;

EID: 80052796955     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2011-110176     Document Type: Article

References (72)

1. Taylor M, Rossler J, Geoerger B, Laplanche A, Hartmann O, Vassal G, Farace F (2009) High levels of circulating VEGFR2+ Bone marrow-derived progenitor cells correlate with metastatic disease in patients with pediatric solid malignancies. Clin Cancer Res 15, 4561-4571.
2. Biedler JL, Helson L, Spengler BA (1973) Morphology and growth, tumorigenicity, and cytogeneticsofhuman neuroblas-toma cells in continuous culture. Cancer Res 33, 2643-2652.
3. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR, Reyes M, Lenvik T, Lund T, Blackstad M, Du J, Aldrich S, Lisberg A, Low WC, Largaes-pada DA, Verfaillie CM (2002) Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418, 41-49. (Pubitemid 34742565)
4. Goolsby J, Marty MC, Heletz D, Chiappelli J, Tashko G, Yarnell D, Fishman PS, Dhib-Jalbut S, Bever CT, Jr., Pessac B, Trisler D (2003) Hematopoietic progenitors express neural genes. Proc Natl Acad Sci USA 100, 14926-14931. (Pubitemid 37517993)
5. Thomas SK, Messam CA, Spengler BA, Biedler JL, Ross RA (2004) Nestin is a potential mediator of malignancy in human neuroblastoma cells. J Biol Chem 279, 27994-27999. (Pubitemid 38900069)
6. Biagiotti T, D'Amico M, Marzi I, Di GP, Arcangeli A, Wanke E, Olivotto M (2006) Cell renewinginneuroblastoma: electro-physiological and immunocytochemical characterization of stem cells and derivatives. Stem Cells 24, 443-453. (Pubitemid 44464814)
7. Marzi I, D'Amico M, Biagiotti T, Giunti S, Carbone MV, Fredducci D, Wanke E, Olivotto M (2007) Purging of the neuroblastoma stem cell compartment and tumor regression on exposure to hypoxia or cytotoxic treatment. Cancer Res 67, 2402-2407. (Pubitemid 46548922)
8. Walton JD, Kattan DR, Thomas SK, Spengler BA, Guo HF, Biedler JL, Cheung NK, Ross RA (2004) Characteristics of stem cells from human neuroblastoma cell lines andin tumors. Neoplasia 6, 838-845. (Pubitemid 40041503)
9. Rettig WJ, Spengler BA, Chesa PG, Old LJ, Biedler JL (1987) Coordinate changes in neuronal phenotype and surface antigen expression in human neuroblastoma cell variants. Cancer Res 47, 1383-1389. (Pubitemid 17023212)
10. Ross RA, Spengler BA, Biedler JL (1983) Coordinate morphological and biochemical interconversion of human neuroblastoma cells. J Natl Cancer Inst 71, 741-747. (Pubitemid 14232388)
11. Paley EL, Denisova G, Sokolova O, Posternak N, Wang X, Brownell AL (2007) Tryptamine induces tryptophanyl-tRNA synthetase-mediated neurodegeneration with neurofibrillary tangles in human cell and mouse models. Neuromolecular Med 9, 55-82. (Pubitemid 44772276)
12. Luscombe G, Jenner P, Marsden CD (1982) Tryptamine-induced myoclonus in guinea-pigs pretreated with a monoamine oxidase inhibitor indicates pre-and post-synaptic actions of tryptamine upon central indoleamine systems. Neu-ropharmacology 21, 1257-1265. (Pubitemid 13196687)
13. Paley EL, Baranov VN, Alexandrova NM, Kisselev LL (1991) Tryptophanyl-tRNA synthetase in cell lines resistant to tryp-tophan analogs. Exp Cell Res 195, 66-78. (Pubitemid 121006296)
14. Paley EL (1999) Tryptamine-mediated stabilization of tryptophanyl-tRNA synthetase in human cervical carcinoma cell line. Cancer Lett 137, 1-7. (Pubitemid 29179490)
15. Herrera F, Martin V, Carrera P, Garcia-Santos G, Rodriguez-Blanco J, Rodriguez C, Antolin I (2006) Tryptamine induces cell death with ultrastructural features of autophagy in neu-rons and glia: Possible relevance for neurodegenerative disorders. Anat Rec ADiscov Mol Cell Evol Biol 288, 1026-1030. (Pubitemid 44306848)
16. Yadav MC, Burudi EM, Alirezaei M, Flynn CC, Watry DD, Lanigan CM, Fox HS (2007) IFN-gamma-induced IDO and WRS expression in microglia is differentially regulated by IL-4. Glia 55, 1385-1396. (Pubitemid 47328941)
17. Pajot B, Sarger C, Bonnet J, Garret M (1994) An alternative splicing modifies the C-terminal end of tryptophanyl-tRNA synthetase in murine embryonic stem cells. J Mol Biol 242, 599-603. (Pubitemid 24327224)
18. Fodinger M, Fritsche-Polanz R, Buchmayer H, Skoupy S, Sengoelge G, Horl WH, Sunder-Plassmann G (2000) Erythropoietin-inducible immediate-early genes in human vascular endothelial cells. J Investig Med 48, 137-149.
19. Wang L, Zhang Z, Wang Y, Zhang R, Chopp M (2004) Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats. Stroke 35, 1732-1737. (Pubitemid 38823656)
20. Krause SW, Rehli M, Kreutz M, Schwarzfischer L, Paulauskis JD, Andreesen R (1996) Differential screening identifies genetic markers of monocyte to macrophage maturation. J Leukoc Biol 60, 540-545. (Pubitemid 26356781)
21. Medbury HJ, Tarran SL, Guiffre AK, Williams MM, Lam TH, Vicaretti M, Fletcher JP (2008) Monocytes contribute to the atherosclerotic cap by transformation into fibrocytes. Int Angiol 27, 114-123. (Pubitemid 351796013)
22. Seshaiah P, Andrew DJ (1999) WRS-85D: A tryptophanyl-tRNA synthetase expressed to high levels in the developing Drosophila salivary gland. Mol Biol Cell 10, 1595-1608. (Pubitemid 29230911)
23. Ghanipour A, Jirstrom K, Ponten F, Glimelius B, Pahlman L, Birgisson H (2009) The prognostic significance of tryptophanyl-tRNA synthetase in colorectal cancer. Cancer Epidemiol Biomarkers Prev 18, 2949-2956.
24. 2 and COOH termini of mammalian tryptophanyl-tRNA synthetase reveal link of the epitopes to aggregation and Alzheimer's disease. Mol Immunol 44, 541-557. (Pubitemid 44376415)
25. Kelly BM, Gillespie CS, Sherman DL, Brophy PJ (1992) Schwann cells of the myelin-forming phenotype express neu-rofilament protein NF-M. J Cell Biol 118, 397-410.
26. Portelius E, Brinkmalm G, Tran A, Andreasson U, Zetterberg H, Westman-Brinkmalm A, Blennow K, Ohrfelt A (2010) Identification of novel N-terminal fragments of amyloid precursor protein in cerebrospinal fluid. Exp Neurol 223, 351-358.
27. Hol EM, Roelofs RF, Moraal E, Sonnemans MA, Sluijs JA, Proper EA, deGraan PN, Fischer DF, van Leeuwen FW (2003) Neuronal expression of GFAP in patients with Alzheimer pathology and identification of novel GFAP splice forms. Mol Psychiatry 8, 786-796. (Pubitemid 37100712)
28. Imura T, Kornblum HI, Sofroniew MV (2003) The predominant neural stem cell isolated from postnatal and adult forebrain but not early embryonic forebrain expresses GFAP. J Neurosci 23, 2824-2832. (Pubitemid 36418618)
29. Mancardi GL, Cadoni A, Tabaton M, Schenone A, Zicca A, De M, I, Bianchini D, Damiani G, Zaccheo D (1991) Schwann cell GFAP expression increases in axonal neuropathies. J Neurol Sci 102, 177-183.
30. Bianchini D, De M, I, Cadoni A, Zicca A, Tabaton M, Schenone A, Anfosso S, kkad Wattar AS, Zaccheo D, Mancardi GL (1992) GFAP expression of human Schwann cells in tissue culture. Brain Res 570, 209-217.
31. Ross RA, Biedler JL, Spengler BA (2003) A role for distinct celltypesindetermining malignancyinhumanneuroblastoma cell lines and tumors. Cancer Lett 197, 35-39. (Pubitemid 36859987)
32. Mora J, Cheung NK, Juan G, Illei P, Cheung I, Akram M, Chi S, Ladanyi M, Cordon-Cardo C, Gerald WL (2001) Neu-roblastic and Schwannian stromal cells of neuroblastoma are derived from a tumoral progenitor cell. Cancer Res 61, 6892-6898. (Pubitemid 32896515)
33. Neumuller J, Neumuller-Guber SE, Lipovac M, Mosgoeller W, Vetterlein M, Pavelka M, Huber J (2006) Immunological and ultrastructural characterization of endothelial cell cultures differentiated from human cord blood derived endothelial progenitor cells. Histochem Cell Biol 126, 649-664. (Pubitemid 44899709)
34. Takahashi K, Nakashima N, Kuwahara M, Sugimoto K, Inui K, Harada T, Maita K (1997) Intraabdominal lymphan-giosarcoma in a Fischer-344 rat. Toxicol Pathol 25, 403-406.
35. Meban C (1973) The pneumonocytes in the lung of Xenopus laevis. J Anat 114, 235-244.
36. Walia V, Elble RC (2010) Enrichment for breast cancer cells with stem/progenitor propertiesbydifferential adhesion.Stem Cells Dev 19, 1175-1182.
37. Barrett OJ, Childs JL, Disney MD (2006) Chemical microarrays to identify ligands that bind pathogenic cells. Chembiochem 7, 1882-1885. (Pubitemid 44893520)
38. Bruning G, Rommelspacher H (1984) High affinity (3 H) tryptamine binding sites in various organs of the rat. Life Sci 34, 1441-1446. (Pubitemid 14161213)
39. Schick BP, Senkowski-Richardson S (1992) Proteoglycan synthesis in human erythroleukaemia (HEL) cells. Biochem J 282 (Pt 3), 651-658.
40. Buee L, Ding W, Delacourte A, Fillit H (1993) Binding of secreted human neuroblastoma proteoglycans to the Alzheimer's amyloid A4 peptide. Brain Res 601, 154-163. (Pubitemid 23047677)
41. Brandsma M, Janssen GM, Moller W (1997) Termination of quiescence in crustacea. The role of transfer RNA aminoa-cylation in the brine shrimp Artemia. J Biol Chem 272, 28912-28917. (Pubitemid 27498174)
42. Wainwright LJ, Lasorella A, Iavarone A (2001) Distinct mechanisms of cell cycle arrest control the decision between differentiation and senescence in human neuroblastoma cells. Proc Natl Acad Sci USA 98, 9396-9400. (Pubitemid 32743928)
43. Valentiner U, Valentiner FU, Schumacher U (2008) Expression of CD44 is associated with a metastatic pattern of human neuroblastoma cells in a SCID mouse xenograft model. Tumour Biol 29, 152-160.
44. Heath-Pagliuso S, Rogers WJ, Tullis K, Seidel SD, Cenijn PH, Brouwer A, Denison MS (1998) Activation ofthe Ah receptor by tryptophan and tryptophan metabolites. Biochemistry 37, 11508-11515. (Pubitemid 28388192)
45. Akahoshi E, Yoshimura S, Ishihara-Sugano M (2006) Over-expression of AhR (aryl hydrocarbon receptor) induces neural differentiation of Neuro2a cells: neurotoxicology study. Environ Health 5, 24.
46. Iborra F, Dorizzi M, Labouesse J (1973) Tryptophanyl-transfer ribonucleic-acid synthetase from beef pancreas. Ligand binding and dissociation equilibrium between the active dimeric and inactive monomeric structures. Eur J Biochem 39, 275-282.
47. Wright CI, Guela C, Mesulam MM (1993) Protease inhibitors and indoleamines selectively inhibit cholinesterases in the histopathologic structures of Alzheimer disease. Proc Natl Acad Sci USA 90, 683-686. (Pubitemid 23028928)
48. Xia N, Thodeti CK, Hunt TP, Xu Q, Ho M, Whitesides GM, Westervelt R, Ingber DE (2008) Directional control of cell motility through focal adhesion positioning andspatial control of Rac activation. FASEB J 22, 1649-1659. (Pubitemid 351811443)
49. Milan M, Campuzano S, Garcia-Bellido A (1996) Cell cycling and patterned cell proliferation in the Drosophila wing during metamorphosis. Proc Natl Acad Sci USA 93, 11687-11692. (Pubitemid 26347183)
50. Lopez-Sanchez N, Muller U, Frade JM (2005) Lengthening of G2/mitosis in cortical precursors from mice lacking beta-amyloid precursor protein. Neuroscience 130, 51-60. (Pubitemid 39550414)
51. Ohyagi Y, Asahara H, Chui DH, Tsuruta Y, Sakae N, Miyoshi K, Yamada T, Kikuchi H, Taniwaki T, Murai H, Ikezoe K, Furuya H, Kawarabayashi T, Shoji M, Checler F, Iwaki T, Makifuchi T, Takeda K, Kira J, Tabira T (2005) Intracellular Abeta42 activates p53 promoter: a pathway to neurodegener-ation in Alzheimer's disease. FASEB J 19, 255-257. (Pubitemid 40189273)
52. Perry G, Castellani RJ, Smith MA, Harris PL, Kubat Z, Ghanbari K, Jones PK, Cordone G, Tabaton M, Wolozin B, Ghanbari H (2003) Oxidative damage in the olfactory system in Alzheimer's disease. Acta Neuropathol 106, 552-556. (Pubitemid 37441611)
53. Nemecek GM, Coughlin SR, Handley DA, Moskowitz MA (1986) Stimulation of aortic smooth muscle cell mitogenesis by serotonin. Proc Natl Acad Sci USA 83, 674-678. (Pubitemid 16035536)
54. Karasawa A, Ogihara M, Ishitani R (1987) [3H]tryptamine binding to reconstituted fraction of acidic lipids. J Pharma-cobiodyn 10, 78-84. (Pubitemid 17050826)
55. Han X, Holtzman M, McKeel DW, Jr., Kelley J, Morris JC (2002) Substantialsulfatide deficiency andceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis. J Neurochem 82, 809-818.
56. Stute R, Petridis K, Steinhart H, Biernoth G (2002) Biogenic amines in fish and soy sauces. Eur Food Res Technol 215, 101-107.
57. Zhu X, McShea A, Harris PL, Raina AK, Castellani RJ, Funk JO, Shah S, Atwood C, Bowen R, Bowser R, Morelli L, Perry G, Smith MA (2004) Elevated expression of a regulator of the G2/M phase of the cell cycle, neuronal CIP-1-associated regulator of cyclin B, in Alzheimer's disease. J Neurosci Res 75, 698-703. (Pubitemid 38280709)
58. Helene C, Dimicoli JL, Brun F (1971) Binding of tryptamine and 5-hydroxytryptamine (serotonin) to nucleic acids. Fluorescence and proton magnetic resonance studies. Biochemistry 10, 3802-3809.
59. Koshima H, Honke S (1999) Chiral Bimolecular Crystalliza-tionofTryptamine and Achiral Carboxylic Acids.J Org Chem 64, 790-793. (Pubitemid 29098001)
60. Sacconi S, Salviati L, Nishigaki Y, Walker WF, Hernandez-Rosa E, Trevisson E, Delplace S, Desnuelle C, Shanske S, Hirano M, Schon EA, Bonilla E, De V, DiMauro S, Davidson MM (2008) A functionally dominant mitochondrial DNA mutation. Hum Mol Genet 17, 1814-1820. (Pubitemid 351791508)
61. Scheper GC, van der Knaap MS, Proud CG (2007) Translation matters: protein synthesis defects in inherited disease. Nat Rev Genet 8, 711-723. (Pubitemid 47281987)
62. Tulinius M, Moslemi AR, Darin N, Westerberg B, Wiklund LM, Holme E, Oldfors A (2003) Leigh syndrome with cytochrome-c oxidase deficiency and a single T insertion nt 5537 in the mitochondrial tRNATrp gene. Neuropediatrics 34, 87-91. (Pubitemid 36597128)
63. Parker WD Jr, Filley CM, Parks JK (1990) Cytochrome oxidase deficiency in Alzheimer's disease. Neurology 40, 1302-1303. (Pubitemid 20244999)
64. Kish SJ, Mastrogiacomo F, Guttman M, Furukawa Y, Taanman JW, Dozic S, Pandolfo M, Lamarche J, DiStefano L, Chang LJ (1999) Decreased brain protein levels of cytochrome oxidase subunits in Alzheimer's disease and in hereditary spinocerebellar ataxia disorders: a nonspecific change? J Neurochem 72, 700-707. (Pubitemid 29055233)
65. Buchan JR, Stansfield I (2007) Halting a cellular production line: responses to ribosomal pausing during translation. Biol Cell 99, 475-487. (Pubitemid 47365606)
66. Wills NM, Atkins JF (2006) The potential role of ribosomal frameshifting in generating aberrant proteins implicated in neurodegenerative diseases. RNA. 12, 1149-1153. (Pubitemid 43990539)
67. Andrievskaia O, Algire J, Balachandran A, Nielsen K (2008) Prion protein in sheep urine. J Vet Diagn Invest 20, 141-146. (Pubitemid 352844399)
68. DiFiglia M, Sapp E, Chase KO, Davies SW, Bates GP, Vonsattel JP, Aronin N (1997) Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277, 1990-1993. (Pubitemid 27449140)
69. Ratovitski T, Gucek M, Jiang H, Chighladze E, Waldron E, D'Ambola J, Hou Z, Liang Y, Poirier MA, Hirschhorn RR, Graham R, Hayden MR, Cole RN, Ross CA (2009) Mutant huntingtin N-terminal fragmentsofspecific size mediate aggregation and toxicity in neuronal cells. J Biol Chem 284, 10855-10867.
70. Monaco F, Fumero S, Mondino A, Mutani R (1979) Plasma and cerebrospinal fluid tryptophan in multiple sclerosis and degenerative diseases. J Neurol Neurosurg Psychiatry 42, 640-641. (Pubitemid 9187862)
71. Pratt JA, Jenner P, Johnson AL, Shorvon SD, Reynolds EH (1984) Anticonvulsant drugs alter plasma tryptophan concentrations in epileptic patients: implications for antiepileptic action and mental function. J Neurol Neurosurg Psychiatry 47, 1131-1133. (Pubitemid 14006200)
72. Jin K, Peel AL, Mao XO, Xie L, Cottrell BA, Henshall DC, Greenberg DA (2004) Increased hippocampal neurogenesis in Alzheimer's disease. Proc Natl Acad Sci USA 101, 343-347. (Pubitemid 38084252)